Clinical prognostic value of homologous recombination repair axis markers and PARP1 expression in breast cancer: a systematic review, meta-analysis, and independent cohort validation
{{output}}
Background: Resistance to poly ADP-ribose polymerase (PARP) inhibitors limits durable clinical benefit in breast cancer. The translational relevance of resistance-associated genes to patient prognosis remains poorly characterized... ...
